Brevan Howard Capital Management LP Nuvalent, Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Nuvalent, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 3,519 shares of NUVL stock, worth $271,103. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,519Holding current value
$271,103% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NUVL
# of Institutions
231Shares Held
58.9MCall Options Held
834KPut Options Held
490K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.39 Billion34.87% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.36MShares$413 Million16.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$347 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$233 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.62MShares$202 Million6.84% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.31B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...